Silver Book Fact

AFib practice guidelines reduce direct health care costs

The use of practice guidelines in atrial fibrillation (AF) patients significantly decreased hospitalization and resource utilization—with an average decrease in 30-day total direct health care costs of around $1,400 per patient.

Zimetbaum P, Reynolds M, Ho K, Gaziano T, et al. Impact of a Practice Guideline for Patients with Atrial Fibrillation on Medical Resource Utilization and Costs. Am J Cardiol. 2003; 92(6): 677-81. http://www.ajconline.org/article/S0002-9149(03)00821-X/abstract

Reference

Title
Impact of a Practice Guideline for Patients with Atrial Fibrillation on Medical Resource Utilization and Costs
Publication
Am J Cardiol
Publication Date
2003
Authors
Zimetbaum P, Reynolds M, Ho K, Gaziano T, et al
Volume & Issue
Volume 92, Issue 6
Pages
677-81
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • t-PA cost savings
    The total annual benefit to society from t-PA use in the United States is around $363 million—$60 million in direct cost savings to society plus an additional 7,510 QALYs. This means…  
  • Effects of optimal anticoagulation among AFib patients
    If 50% of individuals with atrial fibrillation who do not receive prophylaxis were optimally anti-coagulated, 19,380 emboli would be prevented and $1.1 billion would be saved each year.  
  • AFib practice guidelines reduce direct health care costs
    The use of practice guidelines in atrial fibrillation (AF) patients significantly decreased hospitalization and resource utilization—with an average decrease in 30-day total direct health care costs of around $1,400 per patient.  
  • Per-patient annual cost of treating stroke in atrial fibrillation patients
    The per-patient annual cost of treating stroke in atrial fibrillation patients was found to be $1,485 in a wellcontrolled anti-coagulation clinic, $3,710 for those receiving warfarin in routine medical care,…  
  • Stroke prevention through optimal anticoagulation
    If half of atrial fibrillation patients who currently receive warfarin in a routine care setting had their anti-coagulation optimized, around 9,000 strokes and more than 29,000 bleeds would be prevented.